MedTrace Logo

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

NCT07043166 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4094

Last updated 2025-09-08

No results posted yet for this study

Summary

The main purpose of this study is to conduct follow-up assessments and update the cardiorenal outcomes among the STONE cohort that was established during 2016-2017. The secondary aim is to compare metabolic risk factors, metabolic disturbances, and clinically relevant metabolic outcomes between the follow-up period and the baseline assessment. The exploratory goal is to examine the relationships between changes in risk factors and clinical outcomes in the participants.

The study is planned to begin in May 2025 and will finalize the data collection for the entire population by June 2026. During this time, participants will be categorized based on CKM staging. The follow-up phase will continue until 2035.

Conditions

  • Metabolic Syndrome
  • Diabetes
  • Obesity and Overweight
  • Hypertension
  • Dyslipidemia
  • Thyroid Diseases
  • Bone Metabolism Disorder
  • Chronic Kidney Disease(CKD)
  • Cardiovascular Diseases (CVD)
  • Cardiovascular-kidney-metabolic Syndrome

Sponsors & Collaborators

  • Shanghai Changzheng Hospital

    lead OTHER

Principal Investigators

  • tuo Li, Prof. · Shanghai Changzheng Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2035-05-30
Completion
2035-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07043166 on ClinicalTrials.gov